Conflicts over pesticide use have increased as new suburbs push up against farming areas in California. In the second part of our series, Sasha Khokha looks at how community residents are looking to document the impact of pesticides on their own health when those chemicals drift off the farm.
Every year California farmers spray more than 150 million pounds of pesticides to keep insects from ravaging crops like almonds, oranges, and grapes. But when those toxins drift onto nearby farmworkers and communities, they sicken hundreds of people each year. California legislators tried to fix the problem five years ago, but new laws don't appear to have made much of a difference.
In this week's Quest radio piece, I talk to two pregnant organic onion workers who got sick after an apple farmer sprayed pesticides on a nearby orchard. Following a nearly three month investigation, the Kern County Ag Commissioner issued citations finding both the apple grower and the organic company at fault.
There's a hidden danger in San Francisco bay: mercury. A potent neurotoxin that can cause serious illness, mercury has been flowing into the bay since the mining days of the Gold Rush Era. It has settled in the bay's mud and made its way up the food chain, endangering wildlife and making many fish unsafe to eat. Now a multi-billion-dollar plan aims to clean it up. But will it work?
Because there wasn't time in the QUEST TV segment on mercury in the bay to include information on safe fish eating practices, below are the guidelines, along with web links, to help you get plenty of Omega 3s and still keep your mercury levels low.
Nearly 15 million Americans suffer from depression. Learn why depression is more than just "feeling blue," the difficulties of treating it with traditional medications and how new tools
and research are shedding light on brain structures that may play an integral role in treating it.
What is the link between anxiety and depression, and can a form of talk therapy help treat both conditions? Learn more in an extended interview with Philippe Goldin, Clinical Research Scientist for the Clinically Applied Affective Neuroscience Group at Stanford University.
Imagine a medical disease that afflicts eighteen million people in the U.S., for which more than 160 million prescriptions were filled in 2008, that is one of the leading causes of disability in the U.S., but a disease for which no definitive medical model of pathology exists.
Why do some people get severely sick from swine flu and others barely feel it? As flu season ramps up, scientists at UCSF's Viral Discovery Center are racing to learn more about the 2009 H1N1 virus, including how it's evolving, and whether our current treatments will remain effective.
We all know that, thanks to our DNA, each of us is a little bit different. Some of those differences are obvious, like eye and hair color, but others are not so obvious, like how our bodies react to medication. Researchers are beginning to look at how to tailor medical treatments to our genetic profiles. Some of the biggest breakthroughs have been in cancer treatment.
You've probably heard about some of the breakthroughs in personal genome sequencing, where companies take a look at your DNA and send back your risk profile. But there's a flip side to all this genetic research that doesn't have to do with risk: personalized medicine.
Even if you are not handling reptiles daily like we are, you can take action to reduce exposure to toxic anti-microbials.
There are health systems around the country that actually have costs that are as much as 20 percent or 30 percent lower than the national average and have higher quality. What is it that they are doing differently from other systems?